Statement from the Chief Public Health Officer of Canada on June 14, 2021

On June 14, 2021, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement on COVID-19.

June 14, 2021 | Ottawa, ON | Public Health Agency of Canada

Today, across the country on World Blood Donor Day, we have another great reason to roll up our sleeves! In addition to putting an arm out for our first or second dose of COVID-19 vaccine, it’s a great day to remember the importance of rolling up a sleeve to donate lifesaving blood and blood products. Your donation of blood and blood products, such as plasma, can help save a life or improve the quality of life of many people, from newborns to seniors. And, there is always a need for blood donations. While donated blood lasts 42 days, platelets, which are used in some cancer treatments lasts only seven days.

To people across Canada who have continued to donate blood and blood products during the pandemic, thank you for your life-changing contributions. Your donations inspire others to help keep Canada’s Lifeline strong! Every donation makes a difference not only to the recipients, but also to their loved ones.

To see if you’re eligible to donate today, Canadians living outside of Quebec can:

• Call 1-888-2-DONATE (1-888-236-6283)
• Book an appointment online at blood.ca
• Download the GiveBlood App from Canadian Blood Services.

Canadians in Quebec can:

• Call 1-888-666-HEMA (1-888-666-4362)
• Book an appointment online at Héma-Québec.

Canadian Blood Services and Héma-Québec have implemented COVID-19 measures, including robust cleaning and screening practices, to protect all donors, staff and volunteers.

As COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity. At the same time, the Public Health Agency of Canada is providing Canadians with regular updates on COVID-19 vaccines administered, vaccination coverage and ongoing monitoring of vaccine safety across the country. The following is the latest summary on national numbers and trends, and the actions we all need to be taking to reduce infection rates, while vaccination programs expand, including acceleration of second dose programs, to better protect people and communities across the country. Due to reduced reporting over the weekend, national seven-day averages have not been updated in today’s statement. These data are still being collected and analysed. I will provide the latest numbers during my remarks tomorrow.

Since the start of the pandemic, there have been 1,402,126 cases of COVID-19 and 25,931 deaths reported in Canada; these cumulative numbers tell us about the overall burden of COVID-19 illness to date. They also tell us, together with results of serological studies, that a large majority of Canadians remain susceptible to COVID-19. However, as vaccination programs expand at an accelerated pace, there is increasing optimism that widespread, stronger and longer lasting immunity can be achieved by fully vaccinating a high proportion of Canadians over the coming weeks and months.

As immunity is still building up across the population, public health measures and individual precautions remain crucial for COVID-19 control. Thanks to measures in place in heavily affected areas and people across Canada continuing with individual precautions, the strong and steady declines in disease trends continues. The latest national-level data show a continued downward trend in disease activity with an average of 1,548 cases reported daily during the latest 7 day period (June 4-10), down 34% compared to the week prior. For the week of May 30-June 5, there were on average of 72,692 tests completed daily across Canada, of which 2.8% were positive for COVID-19, compared to 3.8% the week prior. Until vaccine coverage is sufficiently high to impact disease transmission more broadly in the community, we must sustain a high degree of caution to drive infection rates down to a low, manageable level, and not ease restrictions too soon or too quickly where infection rates are high.

With the considerable decline in infection rates nationally, the overall number of people experiencing severe and critical illness is also steadily declining. Provincial and territorial data indicate that an average of 1,839 people with COVID-19 were being treated in Canadian hospitals each day during the most recent 7-day period (June 4-10), which is 21% fewer than last week. This includes, on average 795 people who were being treated in intensive care units (ICU), 21% fewer than last week. Likewise, the latest 7-day average of 31 deaths reported daily (June 4-10) is continuing to decline, showing a 7% decrease compared to the week prior.

Overall, variants of concern (VOCs) represent the majority of recently reported COVID-19 cases across the country. Four VOCs (B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617, which includes B.1.617.2 (Delta)) have been detected in most provinces and territories.  While the Alpha variant continues to account for the majority of genetically sequenced variants in Canada, we are observing an increase in the Delta variant in some parts of Canada. As Canada continues to monitor and assess genetic variants of the SARS-CoV-2 virus, including impacts in the Canadian context, we know that vaccination, in combination with public health and individual measures, are working to reduce spread of COVID-19.

As vaccine eligibility continues to expand, Canadians are encouraged to get vaccinated and support others to get vaccinated as soon as they are able. As well, with provinces and territories accelerating second dose programs, those who are eligible are urged to get fully vaccinated, including getting the second dose of a two-dose COVID-19 vaccine series. The second immune-boosting dose, substantially lowers our personal risk of infection and serious harms, provides stronger protection against certain variants of concern, including the Delta variant, and may make immunity last longer. Canadians are reminded that it is safe and effective to receive one vaccine product for your first dose and a different vaccine product for your second dose to complete your two-dose vaccine series for optimal protection from COVID-19.

However, regardless of our vaccination status while COVID-19 is still circulating, it is important to remain vigilant, continue following local public health advice, and consistently maintain individual practices that keep us and our families safer, even as the positive impacts of COVID-19 vaccines are building: stay home/self-isolate if you have any symptoms, think about the risks and reduce non-essential activities and outings to a minimum, avoid all non-essential travel, and maintain individual protective practices of physical distancing, hand, cough and surface hygiene and wearing a well-fitted and properly worn face mask as appropriate (including in shared spaces, indoors or outdoors, with people from outside of your immediate household).

For more information regarding the risks and benefits of vaccination, I encourage Canadians to reach out to your local public health authorities, healthcare provider, or other trusted and credible sources, such as Canada.ca and Immunize.ca. Working together, Health Canada, the Public Health Agency of Canada, the National Advisory Committee on Immunization, Canada’s Chief Medical Officers of Health and other health professionals across the country are closely monitoring vaccine safety, effectiveness and optimal use to adapt approaches. As the science and situation evolves, we are committed to providing clear and evidence-informed guidance in order to keep everyone in Canada safe and healthy.

Canadians can also go the extra mile by sharing credible information on COVID-19 risks and prevention practices and measures to reduce COVID-19 in communities. Read my backgrounder to access more COVID-19 Information and Resources on ways to reduce the risks and protect yourself and others, including information on COVID-19 vaccination.

Contacts

Media Relations
Public Health Agency of Canada
613-957-2983
hc.media.sc@canada.ca